Evidence map›Paper›PMID 29371014›Full record

ArticleVaccine2018

Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introduction.

Belinda L Lartey, Susan Damanka, Francis Ekow Dennis, Christabel C Enweronu-Laryea, Emmanuel Addo-Yobo, Daniel Ansong, Sandra Kwarteng-Owusu, Kwamena W Sagoe, Jason M Mwenda, Stanley K Diamenu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Belinda L LarteyNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Susan DamankaNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Francis Ekow DennisNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Christabel C Enweronu-LaryeaSchool of Medicine and Dentistry, University of Ghana, Ghana.
Emmanuel Addo-YoboSchool of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Daniel AnsongSchool of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Sandra Kwarteng-OwusuSchool of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Kwamena W SagoeSchool of Biomedical and Allied Health Sciences, University of Ghana, Ghana.
Jason M MwendaWorld Health Organization (WHO) Regional Office for Africa (WHO/AFRO), Brazzaville, Congo.
Stanley K DiamenuWHO Country Office, Accra, Ghana.
Clement NarhSchool of Public Health, University of Health and Allied Sciences, Ho, Ghana.
Fred BinkaSchool of Public Health, University of Health and Allied Sciences, Ho, Ghana.
Umesh ParasharCenters for Disease Control and Prevention, Atlanta, GA, USA.
Ben LopmanDept. of Epidemiology, Rollins School of Public Health, Emory University, USA.
George E ArmahNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. Electronic address: garmah@noguchi.ug.edu.gh.
Kwame Nkrumah University of Science and Technology · GHNoguchi Memorial Institute for Medical Research · GHUniversity of Ghana · GHUniversity of Health and Allied Sciences · GHCenters for Disease Control and Prevention · USEmory University · USGhana Health Service · GHWorld Health Organization Regional Office for Africa · CG

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

backgroundGhana introduced the monovalent rotavirus vaccine (Rotarix) into its national paediatric vaccination programme in May2012. Vaccine introduction was initiated nationwide and achieved >85% coverage within a few months. Rotavirus strain distribution pre- and post-RV vaccine introduction is reported.

methodsStool samples were collected from diarrhoeic children <5 years of age hospitalized between 2009 and 2016 at sentinel sites across Ghana and analyzed for the presence of group A rotavirus by enzyme immunoassay. Rotavirus strains were characterized by RT-PCR and sequencing.

resultsA total of 1363 rotavirus EIA-positive samples were subjected to molecular characterization. These were made up of 823 (60.4%) and 540 (39.6%) samples from the pre- and post-vaccine periods respectively. Rotavirus VP7 genotypes G1, G2 and G3, and VP4 genotypes P[6] and P[8] constituted more than 65% of circulating G and P types in the pre-vaccine period. The common strains detected were G1P[8] (20%), G3P[6] (9.2%) and G2P[6] (4.9%). During the post-vaccine period, G12, G1 and G10 genotypes, constituted more than 65% of the VP7 genotypes whilst P[6] and P[8] made up more than 75% of the VP4 genotypes. The predominant circulating strains were G12P[8] (26%), G10P[6] (10%) G3P[6] (8.1%) and G1P[8] (8.0%). We also observed the emergence of the unusual rotavirus strain G9P[4] during this period.

conclusionRotavirus G1P[8], the major strain in circulation during the pre-vaccination era, was replaced by G12P[8] as the most predominant strain after vaccine introduction. This strain replacement could be temporary and unrelated to vaccine introduction since an increase in G12 was observed in countries yet to introduce the rotavirus vaccine in West Africa. A continuous surveillance programme in the post-vaccine era is necessary for the monitoring of circulating rotavirus strains and the detection of unusual/emerging genotypes.

Indexed as

GenotypeImmunization ProgramsAntigens, ViralCapsid ProteinsChild, PreschoolFecesGastroenteritisGhanaHumansImmunoenzyme TechniquesInfantPhylogenyPrevalenceRNA, ViralRotavirusRotavirus InfectionsAntigens, ViralCapsid ProteinsRIX4414 vaccineRNA, ViralRotavirus VaccinesVaccines, AttenuatedVP4 protein, RotavirusVP7 protein, RotavirusGhanaMonovalent rotavirus vaccineStrains

Identifiers

PMID29371014
PMCPMC11345725
OpenAlexW2786173736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.